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As time goes on, it appears that everything has become increasingly more expensive. 
With prices rising, it is expected that the product in question has been advanced, improved or 
somehow progressed. On the contrary, healthcare in the United States has not followed the same 
general path. Certain products and services have seen exponential increases in recent years, 
much greater than can be tied to general inflation. Healthcare costs in the United States have 
risen astronomically in recent years, yet the public health outcomes in the nation have not 
maintained the same upward trend. Obesity, specifically continues to see large increases, and the 
current treatment methods appear unable to keep up. Rates of morbidity and mortality associated 
with obesity have seen no decline, yet American citizens continue to pay more and more for their 
health care.  
Compiled evidence suggests that the primary goal of American healthcare spending tends 
not to be the health-related outcomes for patients. Rather, medical care in the United States 
appears to place emphasis on profitable procedures and reimbursement. Thus far, the rising cost 
of healthcare in the United States has not contributed to a promotion of public health and 
wellness. Rising costs for obesity treatment, for example, appear to be a positive trend, but the 
obesity epidemic has seen little to no change.  
To understand the true issue of obesity, one must first understand peripheral factors that 
contribute to a physician’s treatment of the condition. A greater emphasis on the improvement of 
obesity rates by using cost-effective measures has the potential to create public health outcomes 
that benefit patients. Healthcare providers and policy makers should be aware of the weak 
aspects related to obesity treatment prior to allocating more money to the condition. By first 
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evaluating the modern day barriers to treating obesity, the American healthcare system will be 
able to make a more effective use of financial resources. 
Overview of Healthcare Spending in the United States 
Currently, the cost of healthcare in the United States increases drastically each year and 
no stagnation appears to be in the future. If current trends continue, national healthcare spending 
is projected to grow at a rate of 5.5% per year from 2017 to 2026.1 In 2017, 3.5 trillion dollars 
were allocated to healthcare spending nationwide. By 2026, it is projected that healthcare 
spending will reach 5.7 trillion dollars.1 Following these trends, the United States is frequently 
ranked highly for its per capita spending on healthcare.2 As of 2015, 17.8% of the gross domestic 
product was devoted to healthcare spending.3 However, the funds that the United States 
dedicates to healthcare have not necessarily lent themselves to above average public health 
outcomes.  
Although median incomes have increased over time, a large portion of the income has 
been offset by increasing spending for healthcare. In the ten year span of 1999 to 2009, median 
income increased over $20,000. During the same timeframe, a family’s monthly premium for 
private health insurance grew by 128%, from $490 to more than $1,115.4 While incomes have 
risen slightly, people are burdened by the unreasonable increase in healthcare. On average, the 
increased median income was put towards paying for these necessities, like healthcare, instead of 
being put aside for investments or saving for the future. With such increases, it would be 
expected that health outcomes during this 10 year period would see drastic improvements. On 
the contrary, life expectancy was only increased by about one year, while the other 34 countries 
in the Organization for Economic Cooperation and Development averaged an increase of 2.2 
years.4 The United States dropped to the last place on a list of 19 high income countries in terms 
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of amenable mortality in 2003.4 In terms of general disease prevention and treatment, the United 
States spends more than most other countries and has not seen a pay-out for the increased 
spending. If spending more and receiving less has not proven effective, it is conceivable that 
spending less would be worthwhile.  
Wide variations in terms of cost, quality and access to healthcare exist depending on the 
region of the United States. Primarily, this occurs due to differences in the volume and intensity 
of practice.5 Specifically, more densely packed areas of the country are likely to have higher 
healthcare spending. Medicare per capita spending has been seen to be much greater in areas like 
Florida than regions such as Minnesota.5 From a regional perspective, areas like New England 
and the Mid-east states trend towards spending more than the national average.6 Levels of 
spending are dependent on a variety of different variables. For example, regional spending in the 
United States depends on levels of personal income and the percentage of the nearby population 
enrolled in Medicare or Medicaid.6 Specifically, Massachusetts and Connecticut typically spend 
the most on healthcare per capita, but see smaller increases in spending annually.6 While some 
locations are spending more than others, the general theme appears to demonstrate that overall, 
the United States has not made mentionable health outcomes.  
Outlining all of healthcare spending is an overwhelming large task. Rather than 
attempting to outline the entire process, analyzing one specific condition will give insight into 
themes and trends in healthcare spending throughout the nation. A variety of factors contribute to 
a lack of treatment or mistreatment in certain conditions. Often, these factors are completely 
unrelated to financial allocations. The condition of obesity accounts for a large portion of 
healthcare expenditures nationwide. Yet, this spending has not created less obesity. This is not to 
say that more spending causes more obesity, but it has not proven to help. As a result, it becomes 
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crucial to analyze the more intricate reasons and barriers to proper treatment of obesity. 
Hopefully, a proper understanding of these barriers will give healthcare providers and policy 
makers the opportunity to re-allocate spending towards these issues.  
Prior to outlining the finances related to obesity, one must identify the characteristics 
associated with obesity. While many consider themselves well-versed in terms of obesity, there 
are much more complicated dynamics present than many acknowledge. To start, obesity has a 
genetic and biological component. In other words, not all that are obese are “choosing” to do so. 
While there is a large component related to lifestyle factors and choices, one’s genetics must also 
be considered. Additionally, obesity often requires lifelong treatment as there is currently no one 
solution to the condition. Obesity is chronic and progressive; it is much more than simply being 
overweight or carrying additional weight. Instead, it has the potential to develop into more 
serious and chronic issues if not addressed early and properly.7 Finally, obesity is highly 
correlated with one’s mental health. Mental characteristics such as self-esteem, self-efficacy and 
self-worth are often negatively impacted by being characterized as obese.7 So, while many 
associate obesity with one’s choices, laziness and an overall lack of self-control, there are more 
powerful factors at work. 
Understanding Healthcare Expenditures in terms of Obesity 
 Understandably, the country’s total healthcare spending is devoted to treating various 
different diseases and illnesses, and obesity accounts for a large portion of the cost. Estimates for 
the cost of obesity in the United States range from $147 billion to almost $210 billion per year, 
or about 10% of U.S. healthcare spending.8 At face value, these percentages may appear low, 
however that equates to about 1/10 of overall healthcare spending. With so many different 
diseases, illnesses and conditions, it is alarming that 10% of the nation’s healthcare spending is 
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allocated for obesity. Again, although obesity contributes to a decent amount of healthcare 
spending, obesity rates nationwide have not experienced significant declines. More and more 
examples have demonstrated that, although the U.S. spends a significant amount of money on 
healthcare, their citizens are not reaping the benefits. As a result, one must consider other 
rationales for why increased public health spending has not caused positive health outcomes in 
the United States. 
The trillions of dollars spent on healthcare in the United States have not lead to health 
advances above those of citizens in other countries. For example, the United States was recently 
ranked first worldwide in their per capita spending on healthcare.2 Along with this ranking, 
however, infant mortality was ranked 39th, adult female mortality 43rd, adult male mortality 42nd 
and life expectancy fell to the 36th position worldwide.2 Furthermore, a sizeable portion of the 
population still lacks health insurance protection, preventing them from receiving crucial 
treatments.5 With the national funds allocated to healthcare, this fact should come as an outrage. 
Many other countries allocate their spending differently; they spend less, and provide more (if 
not all) of the population with health insurance and basic healthcare. Given the astronomical 
amount of money spent annually on healthcare, one would likely expect a wider range of 
coverage and more positive health outcomes in American citizens. 
Contrary to the large amount of money spent, obesity continues to be a growing issue 
among American citizens. Currently, the CDC reports that 39.8% of people in the United States 
are currently classified as obese, which equates to 93.3 million U.S. adults.9 Obesity is an issue 
more than just for the simple fact of one being overweight. Carrying extra weight leads to 
various comorbidities and medical consequences. Essentially, those that are overweight or obese 
are more likely to have other illnesses, conditions and diseases. As a result, the medical cost for 
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obese individuals is, on average, $1,429 higher than those of normal weight and body mass index 
(BMI).10 Therefore, having more obese individuals in the nation will result in higher healthcare 
expenditures for obesity and in general. It is important to note that these statistics do not account 
for those overweight individuals that are not medically classified as obese or those that are 
unable to report. Thus, a reduction in the number of obese individuals may decrease healthcare 
expenditures and lead to more positive health outcomes.  
A major contributing factor to the additional money spent on obese patients is the various 
comorbidities that are associated with obesity. These comorbidities lead to an increased spending 
and overall lower quality of life. Also, there is currently no acceptable “cure” for obesity.10 
Obese individuals typically find it increasingly difficult to reach a healthy weight in the long 
term. Various issues are correlated with obesity such as one’s mental health, sleep patterns, pain 
tolerance, development of cardiovascular disease, respiratory disease, digestive and endocrine 
diseases.10 Along with the potential development of these conditions comes additional costs for 
the patient. Therefore, the ability to prevent and control for obesity with proper treatment and 
guidance is undeniably important. Policy makers must acknowledge these comorbidities as 
rationale for confronting barriers that exist in regards to obesity treatment.  
  When referring specifically to obesity, one must understand potential barriers to a 
physician properly treating obesity. Although more and more funds are being allocated to the 
overall spending, financially unrelated barriers may be preventing the proper treatment of 
conditions like obesity. Potentially, there are other considerations for improving health in regards 
to obesity. In assessing obesity prevention and treatment of obesity, researchers have discovered 
that self-efficacy has become a setback to healthcare providers properly treating obesity in 
patients.11 Of the sampled population, only 12% of pediatricians reported a high self-efficacy in 
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obesity management.11 Another 39% of sampled physicians claimed to feel potentially effective 
in treating obesity in their patients.11  Healthcare spending, specifically on obesity, has proven to 
increase annually. However, if the pediatricians seeing the cases are unable to address the issue 
due to a lack of self-efficacy, more spending will likely not reduce obesity rates. Low self-
efficacy would need to be addressed in order to make progress on obesity, and likely other 
topics. Rather than simply spending more in general, it may be advantageous to understand 
weaknesses, such as a lack of self-efficacy in pediatricians. 
 In addition to lacking self-efficacy, pediatricians have acknowledged that they 
infrequently receive the ideal amount of time with a patient.12 A lack of time shared between a 
patient and a physician, especially in younger populations, is an obvious disadvantage for proper 
treatment of a condition like obesity. Seeing as though children visit their pediatrician more 
frequently at a young age, pediatricians have the opportunity to begin obesity prevention and 
education early. Ideally, physicians should screen early for unhealthy weight trajectories in order 
to confront obesity early. However, the necessary screenings are time consuming. Likely, the 
underlying issue a patient is having could be more widely understood if more time was allocated 
to each patient. Often, maximizing one’s time is a central goal of healthcare. But, simply because 
more money is being spent and more patients are seen per hour does not mean that the obesity 
rates are on the decline. If physicians do not have the proper amount of time to thoroughly 
discuss obesity with their patients, the situation runs the risk of continuing with the current trend. 
With time as a barrier, there are limitations on how physicians can handle a patient’s 
condition. In spite of this, growing evidence has suggested that pediatricians should incorporate 
counseling on healthy weight management into their regular practice.12 At a minimum, 
physicians should be recommending healthy weight behavior changes such as limiting television, 
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limiting sweet drinks and increasing overall levels of physical activity.12 With time as a barrier, 
adding even the minimum prevention efforts is a challenge for physicians. Yet, one cannot 
expect public health outcomes to improve when pediatricians can barely allocate enough time to 
communicate the most basic information to parents. Undoubtedly, screening for the lifestyle 
factors leading to obesity early on is crucial. Possibly, funds should be shifted towards 
developing a more complete training protocol for pediatricians so that they can address obesity 
with high self-efficacy and with small time frames.  
In conjunction with perceived barriers from physicians, social services and public health 
spending have the ability to combat obesity. By analyzing the ratio of social spending to health 
spending, research has shown that a higher ratio of this results in better health outcomes. By 
allocating state level spending to social services and public health, not just total spending, health 
outcomes have trended positively.13 Evidence has also demonstrated the relationship between 
social determinants and health outcomes.  In order to reduce extreme obesity, more spending in 
general may not be the solution. Rather, reductions in extreme obesity have been associated with 
factors such as the availability of supermarkets.14 By incentivizing healthier food choices by 
creating more convenient locations for supermarkets, public health may see positive, upward 
trends in terms of obesity. Healthcare policy makers should understand such evidence and trends, 
and attempt to allocate resources towards outlets where public health will reap the most benefits.  
Similarly, socioeconomic status of individuals is highly correlated with obesity rates. The 
prevalence of healthy options in low-income neighborhoods is scarce, forcing those with lower 
socioeconomic statuses to revert to unhealthy food options.10 In general, there is a higher cost 
associated with a healthy diet, one that some simply cannot afford. Many are simply unaware of 
healthy options in their neighborhood, further adding to the dilemma. It is advisable that 
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physicians in lower income and urban areas provide strategies for healthy options. Safety 
concerns may prevent walking or outdoor activities, especially in low-socioeconomic, urban 
locations. Physicians located in urban areas may consider supplying adequate resources with 
information on both safe and healthy options for their patients. Regarding obesity, a misinformed 
or underinformed patient is unable to make the proper choices for themselves or their children. 
Therefore, physicians should examine their role as an educator, specifically in cases of low 
socioeconomic status.  
While more and more money is allocated for healthcare and obesity specifically, 
insurance companies impede the management of obesity. As previously mentioned, physician 
self-efficacy in treating obesity in children is at a low. The odds of high self-efficacy were even 
lower than average for physician respondents who reported a lack of non-MD staff 
reimbursement.11 Specifically, reimbursement refers to the dollar amount that doctor’s offices 
receive from the insurance company for the services. The reimbursement process has been seen 
to be an especially long process for Medicare patients, further exacerbating the issue.15 From a 
financial perspective, if a physician knows that insurance companies will not reimburse for their 
services, they may be less likely to address the real issue at hand. With obesity, this becomes 
especially dangerous, making it easier for physicians to avoid investing the maximum effort in 
treating obesity. When asked in a survey, 84% of respondents reported that better reimbursement 
for obesity counseling would be “definitely or somewhat” helpful.11 Given the provided research 
on the obesity epidemic, specifically in children, more money in healthcare should be allocated 
towards reimbursing physicians for their work in preventing and treating obesity and related 
factors.   
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Despite the undeniable need for weight and obesity management services, the low 
reimbursement rates do not support sustainability of the services. Physicians and other healthcare 
providers that deal with obesity are not frequently reimbursed for their contributions. As a result, 
the patients may need to pay out of pocket for the treatment, further discouraging proper medical 
care. Among the barriers to obesity management sited by physicians, over half of physicians 
reported lack of non-MD staff reimbursement as a practice based barrier to obesity management 
and 30% sited lack of MD reimbursement as a barrier.11 These statistics demonstrate the lack of 
value that insurance companies currently place on reimbursing healthcare providers for their 
services in treating obesity. Even in extreme cases, third party payers will deny payment for 
obesity intervention services.16 Undoubtedly, the lack of reimbursement is sending the wrong 
message; insurance companies are conveying a disinterest and disinvolvement in dealing with 
the undeniable issue of obesity. Despite reports, research and recommendations from healthcare 
professionals, the poor reimbursement rates impede appropriate medical intervention regarding 
obesity.  
While high spending appears to not be an indication of positive health outcomes in 
relation to obesity, time has shown to be beneficial in treating obesity. In the span of a five year 
longitudinal study, children five to thirteen years of age were tracked throughout their weight 
loss journey. The study originally was conducted in response to the lack of follow up of obesity 
treatment in early childhood. Within those five years, 48% of the 220 children were no longer 
obese and 72% of them were able to reduce their BMI from their starting value.17 Potentially, the 
crucial aspect to the treatment was not money, rather time.  
From this information, it can be seen that the ability to reach significant weight loss is 
promising with a long term behavioral obesity treatment. Although this type of treatment likely 
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was costly, it also devoted serious time from healthcare providers and allowed behavioral change 
to occur. A long term behavioral obesity treatment has the possibility to make a valuable health 
impact on children with obesity.  
Future Directions  
While this piece did not specifically research other countries spending and health 
outcomes, future texts may benefit from understanding how to mimic the public health outcomes 
of successful countries. From gaining a greater understanding of the healthcare dynamics of 
other countries, the United States may develop a different method for healthcare. Potentially, 
mimicking the insurance policies and coverage that other countries provide their citizens may 
allow the United States to have more positive health outcomes and healthier citizens overall.  
Additional texts may also choose to explore and weigh the benefits and drawbacks of 
universal healthcare coverage. While the topic can be political in nature, it may be worth 
investigating while specifically referring to healthcare and obesity. With many citizens lacking 
health insurance or with inadequate coverage, it becomes increasingly more difficult to ensure 
the obese population has the proper resources. Implementing the strategy of universal healthcare 
may be positive as it would allow everyone to have a baseline resource and general knowledge 
about health.  
The information presented in this document was focused primarily on the spending of 
obesity. In the future, researchers and healthcare professionals may consider addressing specific 
issues unrelated to money in order to improve public health outcomes. Obesity was purposefully 
selected in hopes of demonstrating the overall trend of healthcare expenditures. However, the 
financial dynamics of other diseases and conditions may be important to understand in regards to 
this topic. 
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 Given the presented information and barriers to treating obesity, one should identify the 
need for proper re-evaluation of current treatment methods. Healthcare teams and policy makers 
must adapt obesity management strategies on a case by case basis. The various factors presented 
demonstrate that there is not a concrete solution to treating all cases of obesity. Rather, properly 
identifying and addressing barriers is essential. Finances aside, physicians must identify obesity 
treatment as a justice owed to patients. Addressing the aforementioned barriers has the ability to 
save resources and increase the prospect of long term success in obesity treatment.   
 While there are compelling arguments advocating for a complete re-evaluation of 
healthcare in its entirety, this document does not intend to suggest the former. Rather, there is 
crucial evidence to suggest for a shift in obesity spending towards the visibly weak aspects 
outlined earlier. In such an informed, quickly advancing nation, there is no reason for obesity 
statistics to be so overwhelmingly negative.    
 Rather than allocating more money in general towards obesity, one may consider 
emphasizing certain issues such as time, physician reimbursement and self-efficacy and more 
education. By shifting spending, it is possible that more positive health outcomes would be 
experienced and obesity rates would decline. Regardless of if overall spending decreases, 
positive health related outcomes should be the primary goal. An increase in time allocation to 
patients will further allow for obesity to be properly discussed and addressed. Furthermore, the 
earlier the topic can be addressed, the more beneficial outcomes will be for the patient. In 
focusing on physician self-efficacy and proper patient education, the obesity epidemic will be a 
less daunting issue.  
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With both the financial and health-related research presented, it is clear that devoting 
more money to healthcare does not necessarily yield positive public health outcomes. In this 
case, obesity was the centerpiece of the healthcare discussion. However, it is important to 
acknowledge that the results related to obesity are representative of many other diseases and 
conditions. Obesity is a small part of the healthcare system that highlights the fact that health 
outcomes in the United States do not correlate with the ever-increasing amount of money 
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